Ntenga Syndrome: About an Observation
Author(s) -
Patrice Ntenga,
Kantenga Dieu Merci Kabulo,
H Mbayo,
Christene Bora,
Kamadore Touré,
Dophra Ngoy Nkulu
Publication year - 2020
Publication title -
advances in neurology and neuroscience
Language(s) - English
Resource type - Journals
ISSN - 2690-909X
DOI - 10.33140/an.03.03.03
Subject(s) - levetiracetam , medicine , etiology , status epilepticus , pediatrics , hyperostosis , valproic acid , epilepsy , psychiatry , surgery
Ntenga syndrome, is one of the highly epileptogenic, non-metabolic craniopathy whose aetiology is not yet known. This syndrome makes a differential diagnosis with that of Morgagni-Stewart-Morel which is rare and / or rarely mentioned in current clinical practice (entity made of frontal hyperostosis, neuropsychiatric and endocrine disorders). We report here a 58 years old female patient from Lubumbashi/ Democratic republic of Congo, followed for several years for multiform seizures, in whom the explorations of a status epilepticus, made possible to set up a new syndromic entity, called Ntenga syndrome made of a symptomatic triad (persistent multiform epileptic seizures, absence of endocrine disorder, hyperostosis frontalis interna). To date, a therapeutic protocol made of valproic acid and levetiracetam has significantly reduced to one seizure per month or even every 2 months. I think it is not without interest to report a very rare and / or new entity in the clinic.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom